Stocks and Investing Stocks and Investing
Thu, December 26, 2019
Tue, December 24, 2019
Mon, December 23, 2019
Fri, December 20, 2019
Thu, December 19, 2019
Wed, December 18, 2019
Tue, December 17, 2019

David Lewis Maintained (ABT) at Buy with Increased Target to $101 on, Dec 17th, 2019


Published on 2024-10-26 19:15:48 - WOPRAI, David Lewis
  Print publication without navigation


David Lewis of Morgan Stanley, Maintained "Abbott Laboratories" (ABT) at Buy with Increased Target from $93 to $101 on, Dec 17th, 2019.

David has made no other calls on ABT in the last 4 months.



There are 2 other peers that have a rating on ABT. Out of the 2 peers that are also analyzing ABT, 0 agree with David's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with David


  • Matt Miksic of "Credit Suisse" Maintained at Buy with Increased Target to $98 on, Thursday, October 17th, 2019
  • Jayson Bedford of "Raymond James" Maintained at Buy with Decreased Target to $90 on, Monday, October 14th, 2019